Proton pump inhibitors (PPIs) are a class of very effective ... Rolaids, and Tums, or acid-reducing drugs known as H2 blockers, such as cimetidine (Tagamet), famotidine (Pepcid), nizatidine ...

A retrospective study revealed that the link between early-life acid-suppressive therapy use and celiac disease autoimmunity may be confounded by healthcare utilization behavior.

Tel Aviv University-led research has found that infants prescribed acid-suppressive medications during their first six months ...

Sagimet Biosciences Inc.’s SGMT share price has dipped by 16.27%, which has investors questioning if this is right time to buy.

Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United ...

First developed in the 1960s, tranexamic acid, an inhibitor of plasminogen activation and fibrinolysis, found niche applications in treating hereditary bleeding disorders. The indications for drugs ...

Huons Global Co. Ltd. has described reversible H+/K+ ATPase inhibitors, particularly acid pump antagonists (APA), reported to be useful for the treatment of gastric and duodenal ulcers, gastritis, ...